Abstract

Advances in the understanding of the genome, combined with affordable sequencing techniques and innovations in drug development, are ushering in an era of molecular diagnostics and individualized therapeutics with the potential to meaningfully enhance human health through effective prevention, diagnosis, and treatment. As the genetic origins of many diseases become better understood, risks and prognoses can be assessed based upon knowledge of genetic mutations, while biomarkers are becoming available to predict pharmacologic response in unique patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call